Goodbye to the symptoms of postpartum depression

Goodbye to the symptoms of postpartum depression

There is no doubt that “postpartum depression” is considered one of the most prominent problems that a mother may face after giving birth to her fetus, but good news has emerged that may end this problem.

Researchers have discovered that giving the mother a ketamine derivative after giving birth contributes to reducing the incidence of major depressive episodes, according to a study published in the British Medical Journal on Thursday.

The study added that mothers with prenatal depression taking a single low dose of esketamine shortly after giving birth led to a three-quarters reduction in major depressive episodes.

They also continued that the clinical trial conducted in China showed that it is to avoid postpartum depression in mothers who previously suffered symptoms of depression during pregnancy, which is a form of so-called prenatal depression that often continues after the birth of the child.

To test the effectiveness of this medication in reducing postpartum depression, researchers formed a group that included hundreds of mothers who suffered from symptoms of depression during pregnancy. Within 40 minutes following delivery, half of them received an esketamine injection, while the other half received a placebo. After 42 days, a severe depressive episode was recorded in less than 7 percent of the first group, while the percentage reached a quarter in the second group.

Many cases of side effects were observed, but they quickly disappeared in less than one day.

Although these results confirm the effectiveness of esketamine in this field, there are several elements that limit its reliability for many reasons.

Injection and controversy

It is noteworthy that the drug “esketamine”, which usually helps in improving the psychological state, is used in this case in the form of an injection, as the basis for an anesthetic product, as the US Food and Drug Administration has previously approved its use as an antidepressant.

In contrast, this drug causes controversy regarding its lack of effectiveness against more resistant types of depression, as well as neuropsychiatric side effects such as speech difficulties or dissociative disorder (multiple personality disorder).

Pisces love horoscope for the year 2024